Amit Bar-Or
Amit Bar-Or
Verified email at
Cited by
Cited by
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis
SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ...
New England Journal of Medicine 358 (7), 676-688, 2008
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ...
New England Journal of Medicine 367 (12), 1098-1107, 2012
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
P Shen, T Roch, V Lampropoulou, RA O’Connor, U Stervbo, E Hilgenberg, ...
Nature 507 (7492), 366-370, 2014
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis
M Duddy, M Niino, F Adatia, S Hebert, M Freedman, H Atkins, HJ Kim, ...
The Journal of Immunology 178 (10), 6092-6099, 2007
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
TA Barr, P Shen, S Brown, V Lampropoulou, T Roch, S Lawrie, B Fan, ...
Journal of Experimental Medicine 209 (5), 1001-1010, 2012
Rituximab in relapsing‐remitting multiple sclerosis: a 72‐week, open‐label, phase I trial
A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ...
Annals of neurology 63 (3), 395-400, 2008
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
A Bar‐Or, L Fawaz, B Fan, PJ Darlington, A Rieger, C Ghorayeb, ...
Annals of neurology 67 (4), 452-461, 2010
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays
PJ Waters, A McKeon, MI Leite, S Rajasekharan, VA Lennon, A Villalobos, ...
Neurology 78 (9), 665-671, 2012
Comparison of polarization properties of human adult microglia and blood‐derived macrophages
BA Durafourt, CS Moore, DA Zammit, TA Johnson, F Zaguia, MC Guiot, ...
Glia 60 (5), 717-727, 2012
Ofatumumab versus teriflunomide in multiple sclerosis
SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, ...
New England Journal of Medicine 383 (6), 546-557, 2020
Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions
B Banwell, A Ghezzi, A Bar-Or, Y Mikaeloff, M Tardieu
The Lancet Neurology 6 (10), 887-902, 2007
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
JM Burton, S Kimball, R Vieth, A Bar-Or, HM Dosch, R Cheung, D Gagne, ...
Neurology 74 (23), 1852-1859, 2010
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
A Bar‐Or, RK Nuttall, M Duddy, A Alter, HJ Kim, I Ifergan, CJ Pennington, ...
Brain 126 (12), 2738-2749, 2003
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses
PW O’connor, D Li, MS Freedman, A Bar-Or, GPA Rice, C Confavreux, ...
Neurology 66 (6), 894-900, 2006
Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
A Monsonego, V Zota, A Karni, JI Krieger, A Bar-Or, G Bitan, AE Budson, ...
The Journal of clinical investigation 112 (3), 415-422, 2003
Distinct profiles of human B cell effector cytokines: a role in immune regulation?
ME Duddy, A Alter, A Bar-Or
The Journal of Immunology 172 (6), 3422-3427, 2004
The system can't perform the operation now. Try again later.
Articles 1–20